Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eiji Shinya
A Possible Mechanism of Intravesical BCG Therapy for Human Bladder Carcinoma: Involvement of Innate Effector Cells for the Inhibition of Tumor Growth
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Related publications
Bilateral Uveitis After Intravesical BCG Immunotherapy for Bladder Carcinoma
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
The Use of Intravesical BCG in Urothelial Carcinoma of the Bladder
ecancermedicalscience
Cancer Research
Oncology
Percutaneous BCG Enhances Innate Effector Antitumor Cytotoxicity During Treatment of Bladder Cancer: A Translational Clinical Trial
OncoImmunology
Oncology
Allergy
Immunology
Intravesical Therapy – BCG and Beyond
Bladder Cancer
Oncology
Urology
Intravesical Mitomycin Therapy for Stage T1 and Tis High-Grade Squamous Cell Carcinoma of the Bladder
Clinical Genitourinary Cancer
Oncology
Urology
Intravesical Administration of Misonidazole in Bladder Carcinoma
Acta Radiologica: Oncology
Intravesical Therapy for Bladder Cancer: Now and Future
Drug Delivery System
Pharmaceutical Science
Effector Mechanism of Magnolol-Induced Apoptosis in Human Lung Squamous Carcinoma CH27 Cells
British Journal of Pharmacology
Pharmacology
Intravesical Coxsackievirus A21 Therapy for Non-Muscle Invasive Bladder Cancer
Bladder Cancer
Oncology
Urology